269 studies found for:    Open Studies | "Parasitic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT
Condition: Neurocysticercosis
Interventions: Drug: 7 days of albendazole  15 mg/kg/day;   Drug: 28 days of albendazole 15 mg/kg/day
22 Not yet recruiting Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
Condition: Neurocysticercosis
Interventions: Drug: Oxfendazole;   Drug: Placebo
23 Not yet recruiting Single Ascending Dose Safety Study of Oxfendazole
Condition: Tenia Solium Infection
Interventions: Drug: oxfendazole;   Drug: placebo
24 Recruiting Treatment of Patients With Cysticercosis With Praziquantel or Albendazole
Condition: Cysticercosis
Intervention:
25 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
26 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
27 Recruiting Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia
Conditions: Lymphatic Filariasis;   Onchocerciasis;   Soil Transmitted Helminth (STH) Infections
Intervention: Drug: Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration
28 Unknown  Human Anaplasmosis in Eastern France
Conditions: Anaplasmosis;   Tick-borne Disease;   Ehrlichia
Intervention: Procedure: Blood sampling
29 Not yet recruiting Safety and Immunogenicity Study of Na-GST-1 With or Without CpG
Conditions: Hookworm Infection;   Hookworm Disease
Interventions: Biological: Na-GST-1/Alhydrogel®;   Biological: CpG 10104
30 Recruiting Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD)
Condition: Vivax Malaria
Interventions: Drug: Dihydroartemisinin-Piperaquine;   Drug: Chloroquine
31 Recruiting Time to Become Negative of Three Rapid Diagnostic Tests for Malaria
Condition: Malaria, Falciparum
Intervention:
32 Unknown  Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Conditions: Leishmaniasis;   Leishmaniasis, Mucocutaneous
Intervention: Drug: Miltefosine
33 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
Intervention:
34 Recruiting Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria
Condition: Malaria
Intervention: Device: Mirasol
35 Unknown  Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease
Condition: Chronic Chagas Disease, Indeterminate
Interventions: Drug: E1224;   Drug: Benznidazole;   Drug: Placebo
36 Recruiting Malaria in Early Life Study
Conditions: Plasmodium Falciparum Malaria;   Plasmodium Vivax Malaria
Intervention: Drug: dihydroartemisinin-piperaquine
37 Recruiting Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
38 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
39 Recruiting A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Dihydroartemisinin + Piperaquine tetraphosphate;   Drug: Artemether + Lumefantrine
40 Recruiting Malaria Transmission Studies in Mali
Condition: MALARIA, FALCIPARUM
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years